HOME >> BIOLOGY >> NEWS
Prevalence of infection in a population can shape parasite virulence

If necessity is the mother of invention, the coevolutionary arms race is the mother of adaptation. For parasites and hosts engaged in an ongoing battle to gain advantage, those adaptations take many forms. In a new analysis in the premier open access journal PLoS Biology, Stephanie Bedhomme, Yannis Michalakis, and colleagues extend traditional methods of studying the coevolution of parasite virulence and host life history traits by introducing an additional variable: intraspecific competition between hosts. Unsurprisingly, the authors find that infected individuals pay a cost compared to their healthy counterparts. But surprisingly, both infected and uninfected individuals do better when their competitor is infected: parasite costs Vand virulence V therefore depend on the infection status of the competitors and for an infected mosquito, at least, you stand a better chance of getting your wings and leaving the natal lagoon if more of your larval neighbors are infected too.

To study the interplay between parasitism and intraspecific competition, Bedhomme et al. worked with the yellow fever mosquito Aedes aegypti and its natural enemy, the single-celled parasite Vavraia culicis. They divided recently hatched mosquito larvae into groups of 60 larvae, and exposed half of the groups to the parasite. Larvae were then placed two by two into vials. Vials contained either two uninfected larvae, two infected larvae, or one infected and one uninfected individual. Infected pairs took longer to develop than uninfected pairs, as expected. But with infected and uninfected pairs, infected larvae took longer to develop than their healthy partners, meaning they are more likely to succumb to the parasite. Competing against a healthy partner increased virulence by increasing development time. Interestingly, however, infected mosquitoes also fared better when paired with an infected competitor. These results suggest that a high incidence, or pre
'"/>

Contact: Paul Ocampo
press@plos.org
415-624-1224
Public Library of Science
18-Jul-2005


Page: 1 2

Related biology news :

1. Prevalence of overactive bladder is overestimated
2. Risk of common vaginal infection linked to preterm birth appears higher for blacks
3. High rates of HIV infection documented among young Nepalese girls sex-trafficked to India
4. Pets could be source of multiresistant bacteria infections in humans, MU researchers investigate
5. Injection drug use and HIV and HCV infections among Ontario prison inmates
6. Injection drug use the most important risk factor for HIV and HCV infections among Quebec prisoners
7. Mucins stand guard against gut infections
8. Bernese Mountain Dogs prone to Borrelia burgdorferi infection
9. New compound effectively treats fungal infections
10. Researchers discover acquired DNA key to certain bacterial infection
11. PET/CT use expands: Effectively diagnosing graft infections

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Prevalence infection population can shape parasite virulence

(Date:12/10/2014)... California , December 9, 2014 ... with ITN,s BCARD Platform   ... cloud-based enterprise meeting scheduling solutions for business-to-business (B2B) ... the world leader in mobile near-field communication (NFC), ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , ...
(Date:12/4/2014)... Dec. 3, 2014  Crossmatch™, a leading provider ... its DigitalPersona ® Pro Enterprise software and ... deployed throughout First Bank branch locations in ... Carolina and Virginia. First Bank, a progressive ... Pines, North Carolina , selected the Crossmatch ...
(Date:11/21/2014)... -- According to a new market research ... Access Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), ... Geography - Global Forecasts to 2020", published by MarketsandMarkets, ... around $25 Billion in 2014 and is expected to ... of 8.69%. Browse 116 market data Tables ...
Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
(Date:12/19/2014)... -- Decision Resources Group finds that the Asia ... through 2023 as the aging population, increasing adoption of ... all spur procedure volumes. Growth will be particularly rapid ... and India , where rising ... a larger proportion of the population. Other ...
(Date:12/17/2014)... NY (PRWEB) December 16, 2014 The ... changes since 2013, which is why IBISWorld updated its ... industry continues to benefit from an intensified focus on ... proposal for new emission standards for power plants and ... operators. According to IBISWorld Industry Analyst Sarah Kahn, “a ...
(Date:12/17/2014)... 17, 2014 Ipsen Biopharmaceuticals, Inc., ... ADR: IPSEY), today announced that Somatuline® ... Somatuline®) was approved by the U.S. Food and ... neuroendocrine tumors (GEP-NETs) in adult patients with unresectable, ... disease to improve progression-free survival (PFS). , “The ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
Breaking Biology Technology:Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2
Cached News: